BioCentury | Jan 14, 2021
Finance

With €127M series B, cancer vaccine developer IO Biotech raises second-largest European venture round in the past year

...parlayed early clinical data into a €127 million ($154.8 million) series B financing led by HBM Healthcare Investments...
...#), MDX-1106 (Compound #), BMS-936558 (Compound #), nivolumab (Generic), Opdivo (Other) IO102 IO103 Keytruda, pembrolizumab (MK-3475, lambrolizumab) IO Biotech ApS HBM Healthcare Investments University...
BioCentury | Jan 12, 2021
Finance

Jan. 11 Quick Takes: Megarounds for Valo, Visen; plus NuProbe, Sensei

...round, joined by Flagship Pioneering and other existing investors plus new institutional investors including Invus Public Equities, HBM Healthcare Investments...
...Greater China. Sequoia China led the round with participation from OrbiMed Advisors, Sherpa Healthcare Partners, Cormorant, HBM Healthcare Investments...
BioCentury | Jan 7, 2021
Finance

Werewolf’s conditionally-activated cancer therapies draw $72M series B, partnering interest

...Novartis Institutes for BioMedical Research (NIBR).Beyond RA Capital, Werewolf’s new series B investors include Deerfield Management, HBM Healthcare Investments...
BioCentury | Dec 10, 2020
Finance

Dec. 9 Quick Takes: Nuance leads bolus of venture rounds for China’s innovators; plus launches for Hillhouse’s Overland, OSI’s PepGen and Atlas’ Vigil and more

...Investments and GT Fund with participation by existing investors CBC Group, Matrix Partners China and HBM Healthcare Investments...
BioCentury | Dec 1, 2020
Product Development

Nov. 30 Quick Takes: Grail piloting blood test in U.K.; plus Rhythm, Kadmon, venture rounds for Adrenomed, Xbiome, Transition

...will review it using the Project Orbis international review framework.Adrenomed raises €22 millionWellington Partners and HBM Healthcare Investments...
BioCentury | Nov 10, 2020
Finance

Nov. 9 Quick Takes: Biogen sheds $14B in value; plus Ambrx’s 200M round, Decibel’s series D and more

...acids into proteins. New investors included Fidelity Management & Research Co., BlackRock, Cormorant Asset Management, HBM Healthcare Investments...
BioCentury | Oct 28, 2020
Deals

Out of the Arena: With $56M round, spinout Longboard to house trio of neuroscience programs

...33.4% stake, according to a regulatory filing. In addition to Farallon, the syndicate also includes Cormorant, HBM Healthcare Investments...
...collaborators: NoneCorporate partners: Arena Pharmaceuticals Inc.Number of employees: 3Funds raised: $56 millionInvestors: Farallon Capital, Cormorant, HBM Healthcare Investments...
BioCentury | Oct 17, 2020
Deals

Oct. 16 Quick Takes: Dren Bio’s $60M series A; plus Roche, Synairgen, Astellas-iota and more

...BioCapital and new investors including BVF Partners, HBM Healthcare Investments...
BioCentury | Sep 29, 2020
Management Tracks

Garijo picked to succeed Oschmann at Merck KGaA; plus BioShin, Abeona, Rubius, Nimbus, Vizgen

...million in a series A round led by OrbiMed Advisors, with participation by Cormorant Asset Management, HBM Healthcare Investments...
BioCentury | Sep 25, 2020
Finance

Sept. 24 Quick Takes: AveXis vets steer Taysha to IPO; plus Exact Sciences, Monte Rosa, OBiO, Moderna, Immetas and more

...from founding investor Versant Ventures and existing investor New Enterprise Associates. Additional new investors included HBM Healthcare Investments...
Items per page:
1 - 10 of 83
BioCentury | Jan 14, 2021
Finance

With €127M series B, cancer vaccine developer IO Biotech raises second-largest European venture round in the past year

...parlayed early clinical data into a €127 million ($154.8 million) series B financing led by HBM Healthcare Investments...
...#), MDX-1106 (Compound #), BMS-936558 (Compound #), nivolumab (Generic), Opdivo (Other) IO102 IO103 Keytruda, pembrolizumab (MK-3475, lambrolizumab) IO Biotech ApS HBM Healthcare Investments University...
BioCentury | Jan 12, 2021
Finance

Jan. 11 Quick Takes: Megarounds for Valo, Visen; plus NuProbe, Sensei

...round, joined by Flagship Pioneering and other existing investors plus new institutional investors including Invus Public Equities, HBM Healthcare Investments...
...Greater China. Sequoia China led the round with participation from OrbiMed Advisors, Sherpa Healthcare Partners, Cormorant, HBM Healthcare Investments...
BioCentury | Jan 7, 2021
Finance

Werewolf’s conditionally-activated cancer therapies draw $72M series B, partnering interest

...Novartis Institutes for BioMedical Research (NIBR).Beyond RA Capital, Werewolf’s new series B investors include Deerfield Management, HBM Healthcare Investments...
BioCentury | Dec 10, 2020
Finance

Dec. 9 Quick Takes: Nuance leads bolus of venture rounds for China’s innovators; plus launches for Hillhouse’s Overland, OSI’s PepGen and Atlas’ Vigil and more

...Investments and GT Fund with participation by existing investors CBC Group, Matrix Partners China and HBM Healthcare Investments...
BioCentury | Dec 1, 2020
Product Development

Nov. 30 Quick Takes: Grail piloting blood test in U.K.; plus Rhythm, Kadmon, venture rounds for Adrenomed, Xbiome, Transition

...will review it using the Project Orbis international review framework.Adrenomed raises €22 millionWellington Partners and HBM Healthcare Investments...
BioCentury | Nov 10, 2020
Finance

Nov. 9 Quick Takes: Biogen sheds $14B in value; plus Ambrx’s 200M round, Decibel’s series D and more

...acids into proteins. New investors included Fidelity Management & Research Co., BlackRock, Cormorant Asset Management, HBM Healthcare Investments...
BioCentury | Oct 28, 2020
Deals

Out of the Arena: With $56M round, spinout Longboard to house trio of neuroscience programs

...33.4% stake, according to a regulatory filing. In addition to Farallon, the syndicate also includes Cormorant, HBM Healthcare Investments...
...collaborators: NoneCorporate partners: Arena Pharmaceuticals Inc.Number of employees: 3Funds raised: $56 millionInvestors: Farallon Capital, Cormorant, HBM Healthcare Investments...
BioCentury | Oct 17, 2020
Deals

Oct. 16 Quick Takes: Dren Bio’s $60M series A; plus Roche, Synairgen, Astellas-iota and more

...BioCapital and new investors including BVF Partners, HBM Healthcare Investments...
BioCentury | Sep 29, 2020
Management Tracks

Garijo picked to succeed Oschmann at Merck KGaA; plus BioShin, Abeona, Rubius, Nimbus, Vizgen

...million in a series A round led by OrbiMed Advisors, with participation by Cormorant Asset Management, HBM Healthcare Investments...
BioCentury | Sep 25, 2020
Finance

Sept. 24 Quick Takes: AveXis vets steer Taysha to IPO; plus Exact Sciences, Monte Rosa, OBiO, Moderna, Immetas and more

...from founding investor Versant Ventures and existing investor New Enterprise Associates. Additional new investors included HBM Healthcare Investments...
Items per page:
1 - 10 of 83